TScan Therapeutics: Finding Their Footing After An Eventful ASH Meeting

Company Overview - TScan Therapeutics is a biotechnology company focused on developing engineered T cell receptor therapies aimed at treating various forms of cancer [1] Product Development - The company's initial product is an HA-2-directed T cell therapy, which represents their first attempt to enter the cancer treatment market [1] Expertise and Mission - The company emphasizes the importance of understanding the science behind its business and aims to educate investors about the complexities of the biotech industry [1]